Breaking News Instant updates and real-time market news.

CYAD

Celyad

$36.00

(0.00%)

17:07
03/22/18
03/22
17:07
03/22/18
17:07

Celyad reports operating results, expected key milestones for 2018

The company provided an update on its recent operations and reported consolidated financial results for the twelve-month period ended 31 December 2017, prepared in accordance with IFRS.Christian Homsy, CEO of Celyad: "2017 has been another milestone year for Celyad. The responses obtained to date in AML, and in solid tumors, we believe validate NKG2D as a target and allow us to move rapidly forward with the development of this product candidate in 2018. Our intellectual property related to the allogeneic technology, another of our core strengths, has been further strengthened: it was upheld by the US Patent and Trademark Office as part of multiple ex-parte re-examination requests and its importance has been recognized through our licensing agreement with Novartis. As far as 2018 is concerned: we believe it will be an exciting year as we expect to - among other things- complete the dose escalation segment of THINK and explore the various conditions that could lead to a potential registrational Phase 2 trial." Celyad reported steady progress in 2017 with the advancement of the clinical development of CYAD-01. Data collected thus far from the THINK trial, which started in early 2017, show that CYAD-01 has been well-tolerated, offers an excellent safety profile and validates the activity of the NKG2D receptor.In terms of financing, Celyad reported EURO$34Mn at year end 2017. This, together with anticipated milestone payments expected to be received by Celyad in 2018 from its strategic partners, should enable the company to finance all its clinical programs and other needs through the first half of 2019.

CYAD Celyad
$36.00

(0.00%)

10/09/17
PIPR
10/09/17
NO CHANGE
Target $74
PIPR
Overweight
Celyad price target raised to $74 from $49 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff raised his price target for Celyad to $74 after the company last week reported the first ever Morphologic Leukemia-Free Status in an Acute Myeloid Leukemia patient in the first dose cohort of the Phase Ib Think study of CYAD-01 without preconditioning. Fourteen solid and hematologic tumor patients have been dosed in Think and escalation continues with no deaths, Tenthoff tells investors in an intraday research note. He added $258M in value for CYAD-01 in colorectal cancer based on the two patients with stable disease in Think and Celyad's plans to expand enrollment and initiate the Shrink and Link studies. The analyst, who points out his firm has been retained by Celyad as its financial advisor to explore strategic alternatives, reiterates an Overweight rating on the shares.

TODAY'S FREE FLY STORIES

11:30
08/17/18
08/17
11:30
08/17/18
11:30
Options
Continued interest in PHLX Gold and Silver Mining Index puts »

Continued interest in…

CGC

Canopy Growth

$32.74

1.86 (6.02%)

11:25
08/17/18
08/17
11:25
08/17/18
11:25
Options
Canopy Growth call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$33.21

0.13 (0.39%)

, VIA

Viacom

$35.75

0.25 (0.70%)

11:19
08/17/18
08/17
11:19
08/17/18
11:19
Hot Stocks
Box Office Battle: 'Crazy Rich Asians' expected to edge out 'The Meg' »

The major release opening…

T

AT&T

$33.21

0.13 (0.39%)

VIA

Viacom

$35.75

0.25 (0.70%)

VIAB

Viacom

$30.60

0.5 (1.66%)

CMCSA

Comcast

$35.59

-0.07 (-0.20%)

CMCSK

Comcast

$0.00

(0.00%)

FOX

21st Century Fox

$44.86

-0.25 (-0.55%)

FOXA

21st Century Fox

$45.41

-0.3 (-0.66%)

LGF.A

Lionsgate

$22.90

-0.16 (-0.69%)

LGF.B

Lionsgate

$21.71

-0.24 (-1.09%)

SNE

Sony

$54.21

0.385 (0.72%)

DIS

Disney

$112.10

-0.39 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

  • 11

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
08/17/18
08/17
11:17
08/17/18
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
08/17/18
08/17
11:16
08/17/18
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
08/17/18
08/17
11:15
08/17/18
11:15
General news
Treasury Option Action: put butterfly positioning in the belly »

Treasury Option Action:…

BTC

Bitcoin

$0.00

(0.00%)

, BITCOIN

Bitcoin

$0.00

(0.00%)

11:13
08/17/18
08/17
11:13
08/17/18
11:13
Hot Stocks
The Intersection: Crypto and Wall Street This Week »

As bitcoin, ethereum and…

BTC

Bitcoin

$0.00

(0.00%)

BITCOIN

Bitcoin

$0.00

(0.00%)

TSM

TSMC

$39.87

-0.55 (-1.36%)

NVDA

Nvidia

$247.00

-10.57 (-4.10%)

AMD

AMD

$19.48

0.14 (0.72%)

OSTK

Overstock.com

$30.75

0.55 (1.82%)

DPW

DPW Holdings

$0.42

0.019 (4.76%)

KODK

Kodak

$2.90

-0.1 (-3.33%)

SSC

Seven Stars Cloud Group

$1.99

0.01 (0.51%)

RIOT

Riot Blockchain

$5.35

-0.055 (-1.02%)

TEUM

Pareteum

$2.52

-0.01 (-0.40%)

SRAX

Social Reality

$4.18

-0.16 (-3.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

  • 28

    Aug

  • 12

    Sep

11:05
08/17/18
08/17
11:05
08/17/18
11:05
General news
The U.S. QSS figures »

The U.S. QSS figures that…

NVDA

Nvidia

$247.12

-10.45 (-4.06%)

, ESPR

Esperion

$48.10

1.41 (3.02%)

11:04
08/17/18
08/17
11:04
08/17/18
11:04
Recommendations
Fly Intel: Today's top analyst calls on Wall Street »

Check out today's…

NVDA

Nvidia

$247.12

-10.45 (-4.06%)

ESPR

Esperion

$48.10

1.41 (3.02%)

DSW

DSW

$25.85

-1.97 (-7.08%)

MTCH

Match Group

$46.87

0.49 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 12

    Sep

  • 12

    Sep

FIBK

First Interstate

$45.20

(0.00%)

11:02
08/17/18
08/17
11:02
08/17/18
11:02
Hot Stocks
First Interstate completes acquisition of Northwest Bancorporation »

Effective August 16,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

LB

L Brands

$32.34

0.24 (0.75%)

11:00
08/17/18
08/17
11:00
08/17/18
11:00
Options
Defensive one-week option play in L Brands ahead of earnings »

Defensive one-week option…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Aug

SYMC

Symantec

$19.44

0.115 (0.60%)

10:40
08/17/18
08/17
10:40
08/17/18
10:40
Options
Symantec sees in the money put buying »

Symantec sees in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

DE

Deere

$136.75

-0.63 (-0.46%)

10:39
08/17/18
08/17
10:39
08/17/18
10:39
Hot Stocks
Breaking Hot Stocks news story on Deere »

Deere says cash use…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

TSLA

Tesla

$313.73

-21.73 (-6.48%)

10:37
08/17/18
08/17
10:37
08/17/18
10:37
Technical Analysis
Technical Take: Tesla nearing bearish head and shoulders target »

In a note published here…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

PK

Park Hotels & Resorts

$32.15

-0.19 (-0.59%)

10:36
08/17/18
08/17
10:36
08/17/18
10:36
Hot Stocks
Park Hotels & Resorts mentioned positively by Hedgeye »

Hedgeye made positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:35
08/17/18
08/17
10:35
08/17/18
10:35
General news
FX Action: Cable is set to rack up a sixth consecutive week of declines »

FX Action: Cable is set…

WBK

Westpac Banking

$21.99

0.09 (0.41%)

10:33
08/17/18
08/17
10:33
08/17/18
10:33
Downgrade
Westpac Banking rating change  »

Westpac Banking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

DE

Deere

$137.29

-0.09 (-0.07%)

10:31
08/17/18
08/17
10:31
08/17/18
10:31
Hot Stocks
Deere expects FY18 net operating cash flows from equipment operations $3.5B »

Says had another…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

SPY

SPDR S&P 500 ETF Trust

$283.54

-0.55 (-0.19%)

10:30
08/17/18
08/17
10:30
08/17/18
10:30
Options
Bullish end of year play in SPYders »

Bullish end of year play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
08/17/18
08/17
10:25
08/17/18
10:25
General news
The Michigan sentiment drop to an 11-month low »

The Michigan sentiment…

GERN

Geron

$3.99

0.04 (1.01%)

10:20
08/17/18
08/17
10:20
08/17/18
10:20
Options
Geron draws far upside call buyers »

Geron draws far upside…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

10:20
08/17/18
08/17
10:20
08/17/18
10:20
General news
U.S. leading indicator rose 0.6% to 110.7 in July »

U.S. leading indicator…

DARE

Dare Bioscience

$1.01

0.01 (1.00%)

, WSC

WillScot

$16.10

0.2 (1.26%)

10:18
08/17/18
08/17
10:18
08/17/18
10:18
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

DARE

Dare Bioscience

$1.01

0.01 (1.00%)

WSC

WillScot

$16.10

0.2 (1.26%)

LGND

Ligand

$237.18

-2.66 (-1.11%)

COT

Cott Corp.

$15.98

0.34 (2.17%)

AZRE

Azure Power

$15.95

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

DF

Dean Foods

$8.01

-0.62 (-7.18%)

, WAB

Wabtec

$108.87

-1.73 (-1.56%)

10:17
08/17/18
08/17
10:17
08/17/18
10:17
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

DF

Dean Foods

$8.01

-0.62 (-7.18%)

WAB

Wabtec

$108.87

-1.73 (-1.56%)

YUMC

Yum China

$34.48

-0.85 (-2.41%)

DSW

DSW

$25.77

-2.05 (-7.37%)

SUI

Sun Communities

$101.22

-0.895 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 10

    Sep

  • 12

    Sep

  • 06

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
08/17/18
08/17
10:17
08/17/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.